Home » Topics » BioWorld Science

BioWorld Science
RSS

ATSO Corp, Cas Biotechnology present antisense oligonucleotides against GST proteins

Aug. 28, 2020

Medibiofarma identifies new prostanoid EP2 and/or EP4 receptor ligands

Aug. 28, 2020

New neurotensin receptor type 2 agonists patented by Socpra Sciences Sante et Humaines SEC

Aug. 28, 2020

Novartis discovers deltaF508 mutant CFTR correctors

Aug. 28, 2020

CKI-alpha/delta inhibitors disclosed by Bayer, Dana-Farber and The Broad Institute

Aug. 28, 2020

Synthetic synaptic protein restores neuronal connections

Aug. 28, 2020

STING agonist JNJ-67544412 shows antitumor activity in syngeneic tumor models

Aug. 28, 2020

Tyme advancing oral synthetic bile acid TYME-19 into clinic for COVID-19

Aug. 28, 2020

Just add fever

Aug. 28, 2020

New phase II study investigates pelareorep with retifanlimab for triple-negative breast cancer

Aug. 27, 2020

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...